Success Metrics

Clinical Success Rate
90.5%

Based on 19 completed trials

Completion Rate
90%(19/21)
Active Trials
1(4%)
Results Posted
11%(2 trials)
Terminated
2(7%)

Phase Distribution

Ph phase_2
5
18%
Ph not_applicable
10
36%

Phase Distribution

0

Early Stage

5

Mid Stage

0

Late Stage

Phase Distribution15 total trials
Phase 2Efficacy & side effects
5(33.3%)
N/ANon-phased studies
10(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

79.2%

19 of 24 finished

Non-Completion Rate

20.8%

5 ended early

Currently Active

1

trials recruiting

Total Trials

28

all time

Status Distribution
Active(1)
Completed(19)
Terminated(5)
Other(3)

Detailed Status

Completed19
Withdrawn3
unknown3
Terminated2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
28
Active
1
Success Rate
90.5%
Most Advanced
Phase 2

Trials by Phase

Phase 25 (33.3%)
N/A10 (66.7%)

Trials by Status

terminated27%
withdrawn311%
completed1968%
active_not_recruiting14%
unknown311%

Recent Activity

Clinical Trials (28)

Showing 20 of 28 trialsScroll for more
NCT00609791Phase 2

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer

Active Not Recruiting
NCT00892515Not Applicable

Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer

Completed
NCT00445445

Changes in Breast Density and Breast Cancer Risk in Women With Breast Cancer and in Healthy Women

Completed
NCT00489125

Strength and Range of Motion in Women Undergoing Surgery for Breast Cancer

Completed
NCT03049358Not Applicable

Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal Cancer

Terminated
NCT02725385

Stress and Coping in Caregivers of Younger Patients With Cancer

Completed
NCT00253669

Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas

Completed
NCT00899496

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

Completed
NCT00458588

Long-Term Effect of Adolescent Diet on Hormones and Breast Cancer Risk in Women Previously Enrolled in the Dietary Intervention Study in Children

Completed
NCT00369460

Changes in Muscle Tissue in Patients With Pancreatic Cancer

Completed
NCT00336102

Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers

Completed
NCT00474812Phase 2

Dasatinib in Treating Patients With Metastatic Pancreatic Cancer

Completed
NCT00081003Not Applicable

Nipple Aspiration, Ductal Lavage, and Duct Endoscopy in Screening Women at Moderate-to-High Risk of Developing Breast Cancer

Completed
NCT00103363Phase 2

Sputum Cytology in Screening Heavy Smokers For Lung Cancer

Completed
NCT00427622Not Applicable

Skin Conduction Device for Measuring Hot Flashes in Postmenopausal Women With Hot Flashes

Completed
NCT00354497Phase 2

Prostate Cancer Screening and Dietary Heterocyclic Amines in African American Men

Unknown
NCT00710632Not Applicable

Screening to Predict Weight Loss in Patients With Cancer

Unknown
NCT00080639

CA-125 in Screening Patients at High Risk for Ovarian Cancer

Withdrawn
NCT00258453Not Applicable

Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma

Completed
NCT00087360Not Applicable

Genetic and Environmental Risk Assessment for Colorectal Cancer in Healthy Participants

Completed

Drug Details

Intervention Type
OTHER
Total Trials
28